Back to Search Start Over

Loperamide metabolite-induced cardiomyopathy and QTc prolongation.

Authors :
Bhatti Z
Norsworthy J
Szombathy T
Source :
Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2017 Aug; Vol. 55 (7), pp. 659-661. Date of Electronic Publication: 2017 Mar 28.
Publication Year :
2017

Abstract

Loperamide is an over-the-counter, peripherally acting, μ-opioid receptor agonist used for the treatment of diarrhea. In recent times users have found that at higher doses, loperamide crosses the blood-brain barrier and reaches central μ-receptors in the brain, leading to central opiate effects including euphoria and respiratory depression. We report a case of a 37-year-old female who attempted suicide with over 200 loperamide tablets. During her overdose, her QTc was significantly prolonged at >600 ms. Our case aims to add to the growing body of literature describing life-threatening ventricular arrhythmias associated with loperamide toxicity and further suggests that a metabolite of loperamide, desmethylloperamide, may play a role in the pathogenesis.

Details

Language :
English
ISSN :
1556-9519
Volume :
55
Issue :
7
Database :
MEDLINE
Journal :
Clinical toxicology (Philadelphia, Pa.)
Publication Type :
Academic Journal
Accession number :
28349724
Full Text :
https://doi.org/10.1080/15563650.2017.1304555